Biologics, Small Molecules
Total Trials
2
As Lead Sponsor
0
As Collaborator
Total Enrollment
427
NCT02904213
Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks
Phase: N/A
Role: Collaborator
Start: Sep 16, 2016
Completion: Jun 24, 2017
NCT05613205
Safety and Immunogenicity of a Novel Conjugate Vaccine Against Salmonella Typhi and Salmonella Paratyphi A in Healthy Adults
Phase: Phase 1
Start: Nov 28, 2022
Completion: Apr 2, 2024
Loading map...